Pluri Inc. — Director's Dealing 2019

Mar 18, 2019

a1922823.xml 1 of 1 03/18/2019 06:25 PM

FORM 3 UNITED STATES SECURITIES AND EXCHANGE

COMMISSION Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person* Franco-Yehuda Chen 0001770681			2. Date of Event Requiring Statement (Month/Day/Year)	3. Issuer Name and Ticker or Trading Symbol PLURISTEM THERAPEUTICS INC [ PSTI ]
(Last) BUILDING NO. 5	(First) MATAM ADVANCED TECHNOLOGY PARK	(Middle)	03/17/2019	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X Officer	10% Owner Other	5. If Amendment, Date of Original Filed (Month/Day/Year)
(Street) HAIFA L3 31905 (City) (State) (Zip)			(give title below) Chief Financial Officer	(specify below)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One X Reporting Person Form filed by More than One Reporting Person

Table I – Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock(1)	77,158(1)	D

Table II – Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise	5. Ownership Form:	6. Nature of Indirect Beneficial
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	Price of Derivative Security	Direct (D) or Indirect (I) (Instr. 5)	Ownership (Instr. 5)

Explanation of Responses:

1. Includes 43,000 shares issuable upon vesting of Restricted Stock Units on various dates ranging from June 30, 2019 to December 31, 2022.

Remarks:

/s/ Chen Franco-Yehuda 03/18/2019

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

OMB APPROVAL

OMB Number: 3235-0104 Estimated average burden hours per response 0.5